Already a DIA Member? Sign in. Not a member? Join.

Iniciar sesión

¿Ha olvidado su ID de usuario? or ¿Ha olvidado su contraseña?

Not a Member?

Create Account and Join

Tommy Douglas Conference Center

02 mar 2020 7:00 a.m. - 03 mar 2020 5:15 p.m.

10000 New Hampshire Ave, Silver Spring, MD 20903

DIA/FDA Advancing Complex Innovative Clinical Trial Designs to Efficiently Deliver Medicines to Patients

Continuing Education

ACPEThe Drug Information Association is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. The Drug Information Association designates this educational activity for up to 13.25 contact hours or 1.325 CEUs.

CE Allocation:

DIA Advancing Complex Innovative Clinical Trial Designs to Efficiently Deliver Medicines to Patients – Day 1: 6.5 contact hours or .65 CEUs Type of Activity: Knowledge, 0286-0000-20-022-L04-P

DIA Advancing Complex Innovative Clinical Trial Designs to Efficiently Deliver Medicines to Patients – Day 2: 6.75 contact hours or .675 CEUs Type of Activity: Knowledge, 0286-0000-20-023-L04-P

ACPE Credit Requests MUST BE SUBMITTED by FRIDAY, APRIL 17, 2020. DIA is required by the Accreditation Council for Pharmacy Education (ACPE) to report pharmacy-requested CEUs through the CPE Monitor system. All ACPE-certified activity credit requests need to be submitted through DIA’s My Transcript within 45-days post activity. If ACPE credit is not requested by Friday, April 17, 2020, the CEU request will not be transmitted through to the CPE Monitor. Pharmacists will need to provide their National Association of Boards of Pharmacy (NABP) e-Profile ID and date of birth (MMDD) to ensure the data is submitted to the ACPE and NABP properly. Obtain your NABP e-Profile.

DIA has been accredited as an Authorized Provider by the International Association for Continuing Education and Training (IACET).

IACET As an IACET Authorized Provider, DIA offers CEUs for its programs that qualify under the ANSI/IACET Standard. DIA is authorized by IACET to offer up to 1.6 CEUs for the program (primer, short courses, and forum, if applicable). Participants must attend the entire forum, primer, and/or short course, if applicable, in order to be able to receive an IACET statement of credit. No partial credit will be awarded.

Continuing Legal Education
For attorneys who would like to receive continuing legal education credits for attending DIA/FDA Advancing Complex Innovative Clinical Trial Designs to Efficiently Deliver Medicines to Patients, please complete your state’s application for credit and submit accordingly. If you require additional information, please contact CE@DIAglobal.org.
NameCredit TypeMax CreditsCEU
DIA/FDA Advancing Complex Innovative Clinical Trial Designs to Efficiently Deliver Medicines to PatientsCredit TypeACPEMax Credits13.25CEU1.325
DIA/FDA Advancing Complex Innovative Clinical Trial Designs to Efficiently Deliver Medicines to PatientsCredit TypeIACETMax Credits13.25CEU1.300

Statement of Credit:

If you would like to receive a statement of credit, you must attend the forum (primer or short course, if applicable), sign in at the registration desk each day, and complete the online credit request process through My Transcript. Participants will be able to download a statement of credit upon successful submission of the credit request. My Transcript will be available for credit requests on Tuesday, March 24, 2020.

Sign in to My Account to access My Transcripts and request your online credit.

To review DIA’s Disclosure and Grievance Policies, visit DIAglobal.org/CE.

¿Tiene una cuenta?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.